Current Issue: 15. 10. 2026, Volume: 39, Issue: 5
In the current issue:
-
Can a negative PSMA PET/CT limit the indication for lymphadenectomy in patients with localized moderate- and high-risk prostate cancer?
Dianová Kristýna et al. -
Prediction of residual disease after chemotherapy in advanced NSGCT – does microRNA provide clinical benefits?
Pokrivčák Tomáš et al. -
Long term response to immunotherapy in a patient with low PD-L1 expression, high tumor mutational burden, and STK11 mutation
Kysela Michal et al.